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Abstract
Background: Meigs’ syndrome is defined as the presence of a benign ovarian tumor with pleural effusion and
ascites that resolve after removal of the tumor. The pathogenesis of the production of ascites and pleural effusion
in this syndrome remains unknown. Aside from pleural effusion and ascites, pericardial effusion is rarely observed in
Meigs’ syndrome. Here, we report the first case of Meigs’ syndrome with preceding pericardial effusion in advance
of pleural effusion.
Case presentation: An 84-year-old Japanese non-smoking woman with a history of lung cancer, treated by
surgery, was admitted due to gradual worsening of dyspnea that had occurred over the previous month. She had
asymptomatic and unchanging pericardial effusion and a pelvic mass, which had been detected 3 and 11 years
previously, respectively. The patient was radiologically followed-up without the need for treatment. Two months
before admission, the patient underwent a right upper lobectomy for localized lung adenocarcinoma and
intraoperative pericardial fenestration confirmed that the pericardial effusion was not malignant. However, she
began to experience dyspnea on exertion leading to admission. A chest, abdomen, and pelvis computed
tomography scan confirmed the presence of right-sided pleural and pericardial effusion and ascites with a left
ovarian mass. Repeated thoracentesis produced cultures that were negative for any microorganism and no
malignant cells were detected in the pleural effusions. Pleural fluid accumulation persisted despite a tube thoracostomy
for pleural effusion drainage. With a suspicion of Meigs’ syndrome, the patient underwent surgical resection of the
ovarian mass and histopathological examination of the resected mass showed ovarian fibroma. Pleural and pericardial
effusion as well as ascites resolved after tumor resection, confirming a diagnosis of Meigs’ syndrome. This clinical course
suggests a strong association between pericardial effusion and ovarian fibroma, as well as pleural and peritoneal fluid.
Conclusions: In female patients with unexplained pericardial effusion and an ovarian tumor, clinicians should consider
the possibility of Meigs’ syndrome. Although a malignant disease should be suspected in all patients with undiagnosed
pleural and/or pericardial effusion, Meigs’ syndrome is curable by tumor resection and should be differentiated from
malignancy.
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Background
Meigs’ syndrome is rare and typically consists of a benign
ovarian fibroma with ascites and pleural effusion that re-
solve after tumor removal [1]. Ovarian fibromas account
for approximately 3 % of all ovarian tumors and Meigs’
syndrome occurs in 1–10 % of these cases [2]. Since Meigs
and Cass (1937) reported a case series of patients who had
ascites and pleural effusion associated with benign ovarian
fibroma [3], this entity has drawn widespread attention
from the medical profession around the world. However,
the pathogenesis of the formation of the ascites and
pleural effusion in Meigs’ syndrome is unknown. It has
been hypothesized that the fluid accumulation in the peri-
toneal cavity may result from an imbalance between fluid
production and lymphatic drainage in association with the
tumor, and the pleural effusion arises secondary to ascites
through passage in the diaphragm [1]. An alternative
hypothesis is that substances like vascular endothelial
growth factor (VEGF), which increase capillary perme-
ability, and some inflammatory cytokines are possible
etiologies of ascites and hydrothorax formation [4]. Al-
though pericardial effusion is a coelomic fluid, as are
pleural effusion and ascites, it rarely occurs in Meigs’
syndrome. Very few cases with such a condition have
been reported in which pericardial effusion was simul-
taneously detected with other findings [5–7]. We de-
scribe the first case of Meigs’ syndrome with preceding
pericardial effusion and discuss the association between
ovarian fibromas and pericardial effusion.
Case presentation
An 84-year-old Japanese woman with a history of lung
cancer treated by surgery was admitted due to gradual
worsening dyspnea over the previous month. She had
had asymptomatic and unchanging pericardial effusion
and a pelvic mass diagnosed 3 and 11 years previously,
respectively, and had been followed-up without the need
for treatment. The chest radiography and magnetic res-
onance imaging of the pelvis 4 months before admission
are shown in Fig. 1a and Fig. 2, respectively. The chest
X-ray showed a nodular shadow in the right lung field
(Fig. 1a), as well as unchanging pericardial effusion volume
revealed by a chest computed tomography (CT) scan
(Fig. 1b). Transbronchial biopsies of the lung nodule were
performed, and the pathological specimen disclosed adeno-
carcinoma. Then, she underwent a right upper lobectomy
for localized lung adenocarcinoma with pericardial fenes-
tration, which confirmed that the pericardial effusion in-
cluded abundant lymphocytes and did not contain any
malignant cells. She progressed favorably after the oper-
ation and was discharged. However, she began to ex-
perience dyspnea on exertion leading to admission. On
admission, she was not suffering from fever, night sweats,
chest discomfort, or abdominal pain. She had a prior
history of pulmonary tuberculosis treated with chemo-
therapy 20 years before and was treated for diabetes
mellitus and hypertension in the hospital. She had no
history of smoking, illicit drug use, recent travel abroad,
or asbestos exposure.
The patient was conscious and afebrile, with a pulse of
108 beats/min, blood pressure of 148/50 mmHg, respira-
tory rate of 28 breaths/min, and oxygen saturation of
90 % in room air, which improved to 96 % on 3 L/min
supplemental oxygen administered intranasally. Pulmon-
ary auscultation revealed a decreased breath sound over
the right lung field. She had normal heart sounds with-
out murmurs. A large, hard, non-tender mass was palp-
able in the lower part of the abdomen. There was no
finger clubbing, cyanosis, lymphadenopathy, or edema in
her extremities.
The complete blood count, blood biochemistry, and
autoantibodies were all unremarkable, except for serum
carcinoembryonic antigen (CEA) at 6.1 ng/mL (normal,
below 5.0 ng/mL) and carbohydrate antigen 125 (CA-
125) at 260 U/mL (normal, below 35 U/mL). The chest
radiography showed cardiac enlargement and right
pleural effusion, as well as blunting of the left costophre-
nic angle (Fig. 1c). Her electrocardiogram (ECG) was
within normal limits. A transthoracic echocardiogram
showed preserved right and left ventricular function with
pericardial effusion. A chest, abdominal, and pelvic CT
scan showed the presence of pericardial and bilateral
pleural effusion and ascites with a left ovarian mass,
20 cm in diameter, without hepatosplenomegaly or lymph-
adenopathy (Fig. 1d). Pericardial effusion had decreased
compared with that before the lung operation. A thora-
centesis revealed clear and yellowish pleural fluid. It was a
lymphocyte-predominant exudate; the total protein level
in the pleural fluid was 3.1 g/dL (6.2 g/dL in serum) and
lactate dehydrogenase (LDH) in pleural fluid was 181 U/L
(238 U/L in serum), which fulfilled Light’s criteria for an
exudate [8]. The adenosine deaminase (ADA) and CEA
levels in the pleural fluid were 9.7 U/L and 2.4 ng/mL, re-
spectively. The bacterial and mycobacterial cultures of the
pleural fluid were negative. Cytological examination of the
pleural fluid showed abundant lymphocytes without any
evidence of malignant cells, similar to that in the pericar-
dial effusion confirmed during the lung surgery.
Despite drainage of the pleural fluid, recurrent episodes
of pleural fluid accumulation occurred requiring weekly
thoracentesis. Despite tube thoracostomy into the right
pleural cavity for drainage, the pleural effusion persisted.
As the combination of her ascites, pleural effusion, and
ovarian mass was suggestive of Meigs’ syndrome, she was
referred to the department of gynecology and underwent
bilateral salpingo-oophorectomy due to strong adhesions
of bilateral ovaries. Histopathological examination of the
resected ovarian mass revealed ovarian fibroma (Fig. 3).
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Thereafter, she made an uneventful recovery and the vol-
ume of pleural and pericardial effusions, as well as ascites,
decreased and subsequently resolved. The follow-up chest
X-ray and CT 8 months after removal of the fibroma con-
firmed no relapse of the pleural and pericardial effusion
(Fig. 1e, f ).
Discussion
Meigs’ syndrome is defined as a condition that meets the
following diagnostic criteria: the presence of pleural effu-
sion and ascites; the existence of benign and solid ovarian
tumors with the gross appearance of a fibroma (fibroma,
thecoma, and granulose cell tumor); and the ascites and
pleural effusion rapidly resolve after removal of the tumor
[1]. In 1887, Demons initially reported nine cases with ovar-
ian cysts that were cured of their ascites and hydrothorax
by removal of the cyst [9]. Thereafter, in 1937, Meigs and
Cass reported a series of seven patients who had ascites
and pleural effusion associated with benign ovarian fibroma
[3]. Meigs’ syndrome is more common in postmenopausal
women with an average age of about 50 years [10]. Since
the original description reported by Meigs, other benign
ovarian tumors and some gynecological conditions associ-
ated with ascites and hydrothorax, such as degenerative
Fig. 1 Representative photographs during the clinical course. Chest X-ray and computed tomography (CT) scan 4 months before admission,
which was 2 months before the lung cancer operation, revealed cardiac enlargement with a nodular shadow (arrow) in the right lung field (a)
and a large volume of pericardial effusion (b). On admission, a chest X-ray showed the right pleural effusion as well as blunting of the left costophrenic
angle (c), and a chest CT scan showed that the pericardial effusion had decreased compared with that before the lung operation (d). No relapse of the
pleural and pericardial effusion was confirmed by chest X-ray or a CT scan 8 months after removal of the fibroma (e, f)
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ovarian changes and ovarian hyperstimulation syndrome,
have been reported and referred to as pseudo-Meigs’ syn-
drome [11, 12].
Meigs’ syndrome with pericardial effusion is a very rare
condition and has been termed Meigs’-like syndrome
[5]. Of three cases in which Meigs’-like syndrome was
suspected [5–7], ovarian fibroma was histopathologically
confirmed in only one case [5]; the ovarian tumor was
not resected in the other two cases. Considering that
pericardial effusion was simultaneously detected with
other findings such as pleural effusion and ascites in the
three cases reported previously, the preceding pericardial
effusion followed by pleural effusion in our case was a
unique presentation.
The pathogenesis of the production of ascites and pleural
effusion in Meigs’ syndrome is unknown. Past reports sug-
gest that the ascitic fluid results from edematous fibromas
that leak fluid or increased lymphangial pressure in the pel-
vis and abdomen caused by the tumor itself [1]. It has also
been supposed that the pleural effusion arises secondary to
the ascites through a congenital defect of the diaphragm or
diaphragmatic lymphatics [1]. In addition, another theory is
that substances such as VEGF that raise capillary perme-
ability and some inflammatory cytokines including interleu-
kin (IL)-1β, IL-6, and IL-8 are possible etiologies of ascites
and hydrothorax formation [4]. VEGF is reportedly associ-
ated with the production of peritoneal and pleural fluid in
patients with malignant and nonmalignant diseases [13].
The increase in VEGF levels in serum, peritoneal, and
pleural fluid in Meigs’ syndrome may be attributable to
VEGF production by the tumor [14]. Unfortunately, the
VEGF level could not be measured in our case.
Although pleural fluid analysis plays an important role
in diagnosing patients with pleural effusion, contradict-
ory data regarding pleural fluid characteristics have been
reported in patients with Meigs’ syndrome, as some
studies have classified it as a transudate [15, 16], whereas
others stated that it is an exudate [17, 18]. Pleural fluid
is generally characterized as either a transudate or an ex-
udate based on Light’s criteria, which assess serum and
pleural fluid protein and LDH [8]. Transudative pleural
effusion occurs in patients with imbalances in hydro-
static and oncotic pressures in the chest, such as chronic
heart failure and nephrosis. In contrast, exudative pleural
effusion results from a variety of mechanisms, including in-
fection, malignancy, and trauma. According to a systematic
review of 653 studies on Meigs’ syndrome, the majority of
pleural effusions in patients are exudates, as is in our case,
despite limited data reliably defining the characteristics of
the pleural effusion [19]. In addition, we needed to carefully
differentiate Meigs’ syndrome from tuberculous pleural
effusion, because the pleural effusion in our case was a
lymphocyte-predominant exudate consistent with tubercu-
lous pleurisy. As acid-fast bacilli stains and cultures are of
Fig. 3 Pathologic findings of the ovarian fibroma. Macroscopic appearance showed a solid and smooth mass (a). Microscopic findings with
hematoxylin and eosin staining showed spindle cells that were arranged in intersecting bundles (b)
Fig. 2 Magnetic resonance imaging of the pelvis before surgery for
lung cancer. An abdominal mass with low signal intensity on
T2-weighted images and ascites was observed
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low yield in the setting of tuberculous pleural effusion, such
negative bacterial findings cannot rule out tuberculous
pleurisy [20]. When the bacterial evaluation of pleural
fluid is not diagnostic, pleural biopsy, culture of pleural
tissue, and an elevated pleural fluid ADA level are often
useful to confirm the diagnosis [21]. Pleural effusion in
our case was unlikely to be caused by tuberculosis, due
to the normal ADA level and the negative mycobacter-
ial culture findings.
High levels of serum CA-125 are suggestive of ovarian
malignancy, and levels have been reported to increase in
Meigs’ syndrome [22]. This antigen is produced by many
clinical tissues, including the epithelium of fallopian tubes,
endometrium, and mesothelium of the pleura, pericar-
dium, and peritoneum [23]. In a previous report, immu-
nohistochemical staining for CA-125 confirmed that the
serum elevation of CA-125 in a patient with Meigs’ syn-
drome was correlated with mesothelial expression of the
antigen rather than the fibroma [24]. Therefore, careful
interpretation is needed in the case of elevated serum CA-
125 levels whenever serosal (peritoneum, pleura, and peri-
cardial) fluid is present as in Meigs’ syndrome [25].
Pericardial effusion can occur in a large variety of under-
lying diseases. A review of 173 consecutive patients under-
going pericardiocentesis reported that the most common
cause was malignancy (33 %), followed by chronic-
idiopathic causes (14 %) [26]. Another study revealed
that the etiology of pericarditis associated with pericardial
effusion was not defined in up to 30 % of patients, despite
the progression of diagnostic techniques such as pericar-
dioscopy and immunohistochemistry [27]. The common
ECG findings in patients with a large volume of pericardial
effusion are sinus tachycardia, low QRS voltage, and elec-
trical alternans [28], which were not seen in our case at
admission or before the lung surgery. Pericardial drainage
is indicated for tamponade, purulent effusion, or for recur-
rent or large idiopathic effusions with hemodynamic com-
promise or suspicion of neoplastic or tuberculous causes
[29]. Cardiac tamponade is a life-threatening entity requir-
ing prompt drainage of pericardial fluid and can occur
when a large volume of pericardial fluid acutely or sub-
acutely accumulates. In contrast, a slow accumulation of
pericardial effusion over several weeks does not increase
pericardial pressure sufficiently to cause symptomatic
cardiac tamponade, despite that the volume of pericardial
effusion can be measured in liters [30]. Although surgical
approaches including pericardial fenestration and peri-
cardiotomy should be considered in cases with recur-
rent large effusion, postoperative pleural effusion that
has moved from the pericardial space through a peri-
cardial window rarely becomes a problem [31]. In our
case, pleural effusion increased after surgery for local-
ized lung cancer with pericardial fenestration, in con-
trast to decreasing pericardial effusion. We speculate
that pericardial effusion, the volume of which had not
changed for more than 3 years due to a closed pericar-
dial space maintaining a well-balanced pericardial pres-
sure, overflowed into the thoracic cavity through a
pericardial window and accumulated as pleural effu-
sion. Similar cytological findings, including abundant
lymphocytes between the peripheral and pleural fluid,
strengthen our hypothesis.
It is of great interest that pericardial effusion preceded
pleural effusion in our case, and not only pleural effu-
sion and ascites but also pericardial effusion disappeared
without reaccumulation after the removal of the ovarian
tumor. Any other possible causes of pericardial effusion,
such as infectious pericarditis, malignancy, and connective
tissue disease, were not plausible in our case, although a
long-term follow-up is necessary to detect signs of lung
cancer recurrence. Therefore, we considered that the peri-
cardial effusion was associated with the ovarian fibroma.
The presence of preceding pericardial effusion cannot be
explained by a common hypothesis suggesting that hydro-
thorax is secondary to ascites in Meigs’ syndrome [1], as it
is difficult for ascites to move directly into the pericardial
space via the peritoneal cavity. Preceding pericardial effu-
sion may imply that substances such as inflammatory
cytokines and hormonal stimulation caused by the tumor
play an important role in the accumulation of fluid in
Meigs’ syndrome. Interestingly, Mertin et al. reported an
atypical case of Meigs’ syndrome with bilateral pleural ef-
fusion and without ascites in a granulosa cell tumor [32].
The most appropriate treatment for Meigs’ syndrome
is removal of the tumor. The pleural effusion and ascites
resolve within a few weeks after tumor resection. A uni-
lateral salpingo-oophorectomy is commonly performed
for the treatment of an ovarian tumor. For women who
desire preservation of the ovary, an ovarian cystectomy
may be performed with complete excision of the fibro-
matous tissue [33]. The prognosis of Meigs’ syndrome is
favorable and recurrence of peritoneal and pleural fluid
after complete removal of the tumor is unlikely to occur.
Conclusion
To the best of our knowledge, this is the first case of Meigs’
syndrome with preceding pericardial effusion in advance of
pleural effusion. It is important for the clinician to consider
the possibility of Meigs’ syndrome in female patients with
unexplained pericardial effusion and an ovarian tumor.
Although a malignant disease should be suspected in all pa-
tients with undiagnosed pleural and/or pericardial effusion,
Meigs’ syndrome is a disease curable by tumor resection
and should be differentiated from malignancy.
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